Explore the Curriculum

Gain a deeper understanding of the strategies for managing HCM.

INTRODUCTION Overview screening MAnagement Special considerations Case studies Key takeaways

Review materials developed by experts to learn about screening for, diagnosing, and managing HCM.

Download The curriculum

1/50

2/50

3/50

4/50

5/50

6/50

7/50

8/50

9/50

10/50

11/50

12/50

13/50

14/50

15/50

16/50

17/50

18/50

19/50

20/50

21/50

22/50

23/50

24/50

25/50

26/50

27/50

28/50

29/50

30/50

31/50

32/50

33/50

34/50

35/50

36/50

37/50

38/50

39/50

40/50

41/50

42/50

43/50

44/50

45/50

46/50

47/50

48/50

49/50

50/50

Continuing Medical Education (CME)

The goal of this activity is to improve the knowledge and competence of learners in
effort to improve screening for and optimize treatment for patients with hypertrophic
cardiomyopathy (HCM).

Upon completion of this activity, participants should be able to:

Recognize guideline recommended screening and diagnosis criteria for HCM, particularly in Black populations.
Discuss latest guideline recommendations in HCM clinical practice.
Discuss new and emerging therapies and HCM guideline-recommended management strategies.

This activity is supported by an educational grant from Bristol Myers Squibb.

Release: August 31, 2025 | Expiration: August 31, 2026

Did You Know?

The first step of Beating HCM is to know the details of the condition.

Diagnosis

Up to 85% of HCM cases remain undiagnosed in the general population—despite the disease affecting approximately 1 in 500 people, making it one of the most common genetic heart disorders.

DISPARITY

Black patients with HCM are more likely to present with heart failure but are less likely to receive life-saving interventions highlighting critical racial disparities in care.

ACCESS

HCM can often be diagnosed non-invasively yet many at-risk patients go untested due to barriers like insurance status, transportation, or provider awareness.

Explore Frequently Asked Questions